# SEVELAMER CARBONATE
> **ANDA219931** · Abbreviated New Drug Application (Generic) · Sponsor: NAVINTA LLC · Approved 2025-10-27
## Drug
- **FDA Application Number:** ANDA219931
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SEVELAMER CARBONATE
- **Generic name:** SEVELAMER CARBONATE
- **Active ingredients:** SEVELAMER CARBONATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NAVINTA LLC
- **Manufacturer:** Zydus Pharmaceuticals USA Inc.
- **First approval:** 2025-10-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219931)
---
*AI Analytics · CC0 1.0*